Miniatura

Fitxers

s41598-021-01992-y.pdf (1.2 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-11-19

Llicència de publicació

cc by (c) Remuzgo Martínez, Sara et al, 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/182728

Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s41598-021-01992-y

Resum

Mucin 1/Krebs von den Lungen-6 (KL-6) is proposed as a serum biomarker of several interstitial lung diseases (ILDs), including connective tissue disorders associated with ILD. However, it has not been studied in a large cohort of Caucasian antisynthetase syndrome (ASSD) patients. Consequently, we assessed the role of MUC1 rs4072037 and serum KL-6 levels as a potential biomarker of ASSD susceptibility and for the differential diagnosis between patients with ILD associated with ASSD (ASSD-ILD +) and idiopathic pulmonary fibrosis (IPF). 168 ASSD patients (149 ASSD-ILD +), 174 IPF patients and 523 healthy controls were genotyped for MUC1 rs4072037 T > C. Serum KL-6 levels were determined in a subgroup of individuals. A significant increase of MUC1 rs4072037 CC genotype and C allele frequencies was observed in ASSD patients compared to healthy controls. Likewise, MUC1 rs4072037 TC and CC genotypes and C allele frequencies were significantly different between ASSD-ILD+ and IPF patients. Additionally, serum KL-6 levels were significantly higher in ASSD patients compared to healthy controls. Nevertheless, no differences in serum KL-6 levels were found between ASSD-ILD+ and IPF patients. Our results suggest that the presence of MUC1 rs4072037 C allele increases the risk of ASSD and it could be a useful genetic biomarker for the differential diagnosis between ASSD-ILD+ and IPF patients.

Matèries

Fibrosi pulmonar, Genètica mèdica

Matèries (anglès)

Pulmonary fibrosis, Medical genetics

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
<b>Publicacions de projectes de recerca finançats per la UE</b>

Citació

REMUZGO MARTÍNEZ, Sara, ATIENZA MATEO, Belén, OCEJO VINYALS, J. gonzalo, GENRE, Fernanda, PULITO CUETO, Verónica, MORA CUESTA, Víctor m., ITURBE FERNÁNDEZ, David, LERA GÓMEZ, Leticia, PÉREZ FERNÁNDEZ, Raquel, PRIETO PEÑA, Diana, IRURE, Juan, ROMERO BUENO, Fredeswinda, SANCHEZ PERNAUTE, Olga, ALONSO MORALEJO, Rodrigo, NUÑO-NUÑO, Laura, BONILLA, Gema, VICENTE RABANEDA, Esther f., GRAFIA, Ignacio, PRIETO GONZÁLEZ, Sergio, NARVÁEZ, Javier, TRALLERO ARAGUAS, Ernesto, SELVA O’CALLAGHAN, Albert, ORTEGO CENTENO, Norberto, PÉREZ GÓMEZ, Nair, MERA, Antonio, MARTÍNEZ BARRIO, Julia, MORIANO, Clara, DÍEZ, Elvira, CALVO ALÉN, Jaime, BALSA, Alejandro, USSETTI, María piedad, LAPORTA, Rosalía, BERASTEGUI, Cristina, SOLÉ, Amparo, GUALILLO, Oreste, CAVAGNA, Lorenzo, CIFRIÁN, José m., RENZONI, Elisabetta a., CASTAÑEDA, Santos, LÓPEZ MEJÍAS, Raquel, GONZÁLEZ GAY, Miguel a., Spanish Biomarkers Of Antisynthetase Syndrome Consortium, Spanish Biomarkers Of Interstitial Lung Disease Consortium. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome. _Scientific Reports_. 2021. Vol.  vol 11, núm. num 1. [consulta: 22 de gener de 2026]. ISSN: 2045-2322. [Disponible a: https://hdl.handle.net/2445/182728]

Exportar metadades

JSON - METS

Compartir registre